Form 4: OPKO Health CEO Phillip Frost Acquires 125,000 Shares

OPKO Health's CEO, Phillip Frost, recently purchased 125,000 shares of the company's common stock at an average price of $1.3577 per share.

Summary

• Phillip Frost, CEO and Chairman of OPKO Health, Inc., acquired 125,000 shares of common stock on April 10, 2025.
• The shares were purchased at a weighted average price of $1.3577, with individual transactions ranging from $1.35 to $1.36.
• Following the transaction, Dr. Frost directly owns 3,568,951 shares.
• Additionally, Dr. Frost has indirect beneficial ownership of 214,001,448 shares through Frost Gamma Investments Trust and 30,127,177 shares through Frost Nevada Investments Trust.
• Dr. Frost disclaims beneficial ownership of the indirectly held securities except to the extent of any pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally a good sign, but it's a single transaction and doesn't provide a comprehensive view of the company's health.

Positives

• The CEO's purchase of shares could be interpreted as a positive signal about his confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's important to consider the overall context of the company's performance and industry trends.

Stakeholder Impact

• Shareholders may view the CEO's purchase as a positive signal.
• The purchase could potentially increase investor confidence.

Key Dates

Keywords

OPKO Health, Phillip Frost, share purchase, Form 4, beneficial ownership, insider trading